Literature DB >> 16783165

High-resolution array-based comparative genomic hybridization of medulloblastomas and supratentorial primitive neuroectodermal tumors.

Martin Gerard McCabe1, Koichi Ichimura, Lu Liu, Karen Plant, L Magnus Bäcklund, Danita M Pearson, Vincent Peter Collins.   

Abstract

Medulloblastomas and supratentorial primitive neuroectodermal tumors are aggressive childhood tumors. We report our findings using array comparative genomic hybridization (CGH) on a whole-genome BAC/PAC/cosmid array with a median clone separation of 0.97 Mb to study 34 medulloblastomas and 7 supratentorial primitive neuroectodermal tumors. Array CGH allowed identification and mapping of numerous novel, small regions of copy number change to genomic sequence in addition to the large regions already known from previous studies. Novel amplifications were identified, some encompassing oncogenes MYCL1, PDGFRA, KIT, and MYB not previously reported to show amplification in these tumors. In addition, one supratentorial primitive neuroectodermal tumor had lost both copies of the tumor-suppressor genes CDKN2A and CDKN2B. Ten medulloblastomas had findings suggestive of isochromosome 17q. In contrast to previous reports using conventional CGH, array CGH identified 3 distinct breakpoints in these cases: Ch 17: 17940393-19251679 (17p11.2, n = 6), Ch 17: 20111990-23308272 (17p11.2-17q11.2, n = 4), and Ch 17: 38425359-39091575 (17q21.31, n = 1). Significant differences were found in the patterns of copy number change between medulloblastomas and supratentorial primitive neuroectodermal tumors, providing further evidence that these tumors are genetically distinct despite their morphologic and behavioral similarities.

Entities:  

Mesh:

Year:  2006        PMID: 16783165      PMCID: PMC2816352          DOI: 10.1097/00005072-200606000-00003

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  37 in total

1.  Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.

Authors:  D A Reardon; J J Jenkins; J E Sublett; P C Burger; L K Kun
Journal:  Pediatr Neurosurg       Date:  2000-04       Impact factor: 1.162

2.  PDGFRB is overexpressed in metastatic medulloblastoma.

Authors:  Richard J Gilbertson; Steven C Clifford
Journal:  Nat Genet       Date:  2003-11       Impact factor: 38.330

3.  DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.

Authors:  Bao-Zhu Yuan; Amy M Jefferson; Kimberly T Baldwin; Snorri S Thorgeirsson; Nicholas C Popescu; Steven H Reynolds
Journal:  Oncogene       Date:  2004-02-19       Impact factor: 9.867

4.  Genotypic analysis of esophageal squamous cell carcinoma by molecular cytogenetics and real-time quantitative polymerase chain reaction.

Authors:  Chueh-Chuan Yen; Yann-Jang Chen; Kai-Hsi Lu; Jiun-Yi Hsia; Jung-Ta Chen; Cheng-Po Hu; Po-Min Chen; Jin-Hwang Liu; Tzeon-Jye Chiou; Wei-Shu Wang; Muh-Hwa Yang; Ta-Chung Chao; Chi-Hung Lin
Journal:  Int J Oncol       Date:  2003-10       Impact factor: 5.650

5.  Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma.

Authors:  Chun-Ming Wong; Joyce Man-Fong Lee; Yick-Pang Ching; Dong-Yan Jin; Irene Oi-lin Ng
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

6.  Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.

Authors:  Carol Y K Tong; Angela B Y Hui; Xiao-Lu Yin; Jesse C S Pang; Xian-Lun Zhu; Wai-Sang Poon; Ho-Keung Ng
Journal:  J Neurosurg       Date:  2004-02       Impact factor: 5.115

7.  Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells.

Authors:  Tai Young Kim; Hyun-Soon Jong; Sang-Hyun Song; Alexandre Dimtchev; Sook-Jung Jeong; Jung Weon Lee; Tae-You Kim; Noe Kyeong Kim; Mira Jung; Yung-Jue Bang
Journal:  Oncogene       Date:  2003-06-19       Impact factor: 9.867

8.  High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization.

Authors:  Carolyn D Hurst; Heike Fiegler; Philippa Carr; Sarah Williams; Nigel P Carter; Margaret A Knowles
Journal:  Oncogene       Date:  2004-03-18       Impact factor: 9.867

9.  Deletion mapping of the medulloblastoma locus on chromosome 17p.

Authors:  P H Cogen; L Daneshvar; A K Metzger; M S Edwards
Journal:  Genomics       Date:  1990-10       Impact factor: 5.736

10.  Gene amplifications associated with the development of hormone-resistant prostate cancer.

Authors:  Joanne Edwards; N Sarath Krishna; Caroline J Witton; John M S Bartlett
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

View more
  34 in total

1.  MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas.

Authors:  Ruth G Tatevossian; Bo Tang; James Dalton; Tim Forshew; Andrew R Lawson; Jing Ma; Geoff Neale; Sheila A Shurtleff; Simon Bailey; Amar Gajjar; Suzanne J Baker; Denise Sheer; David W Ellison
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

2.  Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF).

Authors:  C R Quilter; A C Karcanias; M R Bagga; S Duncan; A Murray; G S Conway; C A Sargent; N A Affara
Journal:  Hum Reprod       Date:  2010-06-22       Impact factor: 6.918

Review 3.  Molecular diagnostics in embryonal brain tumors.

Authors:  Charles G Eberhart
Journal:  Brain Pathol       Date:  2011-01       Impact factor: 6.508

Review 4.  The genetics of pediatric brain tumors.

Authors:  Adrian M Dubuc; Paul A Northcott; Stephen Mack; Hendrik Witt; Stefan Pfister; Michael D Taylor
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 5.  Molecular markers in pediatric neuro-oncology.

Authors:  Koichi Ichimura; Ryo Nishikawa; Masao Matsutani
Journal:  Neuro Oncol       Date:  2012-09       Impact factor: 12.300

6.  Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors.

Authors:  Tea Blom; Annariikka Roselli; Valtteri Häyry; Olli Tynninen; Kirmo Wartiovaara; Miikka Korja; Kristiina Nordfors; Hannu Haapasalo; Nina N Nupponen
Journal:  J Neurooncol       Date:  2009-09-25       Impact factor: 4.130

Review 7.  Evolution in health and medicine Sackler colloquium: Genomic disorders: a window into human gene and genome evolution.

Authors:  Claudia M B Carvalho; Feng Zhang; James R Lupski
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-13       Impact factor: 11.205

8.  Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.

Authors:  Meihua Li; Kyle F Lee; Yuntao Lu; Ian Clarke; David Shih; Charles Eberhart; V Peter Collins; Tim Van Meter; Daniel Picard; Limei Zhou; Paul C Boutros; Piergiorgio Modena; Muh-Lii Liang; Steve W Scherer; Eric Bouffet; James T Rutka; Scott L Pomeroy; Ching C Lau; Michael D Taylor; Amar Gajjar; Peter B Dirks; Cynthia E Hawkins; Annie Huang
Journal:  Cancer Cell       Date:  2009-12-08       Impact factor: 31.743

Review 9.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

10.  Genome-wide analysis of subependymomas shows underlying chromosomal copy number changes involving chromosomes 6, 7, 8 and 14 in a proportion of cases.

Authors:  Kathreena M Kurian; David T W Jones; Faye Marsden; Sam W S Openshaw; Danita M Pearson; Koichi Ichimura; V Peter Collins
Journal:  Brain Pathol       Date:  2008-04-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.